Site networks can play a pivotal role in aligning sponsors, sites, and investigators toward shared goals in oncology clinical trials, but they are not one-size-fits-all. Sponsors must carefully vet site networks to validate that they will deliver strategic value for each individual study. The post Redefining Clinical Oncology Trials: How Agile Site Networks Accelerate Novel Cancer…
With science funding catapulted into the cultural conversation more than ever in the last year, it faces a critical inflection point. There is an opportunity to design a path forward that builds stability in the short term and opens doors in the long term for foundational and transformational science and technology solutions that will benefit…
KFF Health News chief Washington correspondent Julie Rovner discussed the Affordable Care Act subsidies that are set to expire this year and the ongoing federal shutdown on MSNBC’s “The 11th Hour With Stephanie Ruhle” on Oct. 18. Click here to watch Rovner on MSNBC. Rovner also discussed the shutdown and health care costs on WYPR’s…
Insight Timer launched the Therapist Hub, a free platform offering resources to help mental health professionals combat burnout and better support clients. The post Insight Timer Unveils Free Therapist Hub to Support Mental Health Professionals and Ease Burnout appeared first on MedCity News.
Docology is tackling inefficiencies in the patient referral process by using AI to automate and summarize medical records. The company recently won MedCity News’ INVEST Digital Health startup pitch competition, highlighting its potential to fill a critical gap in clinical workflows. The post INVEST Pitch Perfect Spotlight: How Docology Is Automating a Broken Step in…
When the American Cancer Society Cancer Action Network organized its annual citizen lobby day in Washington last month, more than 500 volunteers pushed members of Congress to keep cancer research and support for cancer patients at the top of the nation’s health care agenda. It came as Democrats and Republicans in Washington headed toward a budget impasse over extending the enhanced subsidies that…
GSK drug Blenrep, which exited the market in 2022 after failing a confirmatory study, now has a new FDA approval as a third-line multiple myeloma treatment. The U.S. regulatory decision is more limited than the recent European approval for the blood cancer drug. The post GSK Blood Cancer Drug Returns to the U.S. Market, But…
[Sponsored] California’s leading facial plastic surgeons redefine revision facelifts through precision, innovation and patient-centered artistry. Find out which ones get the best results. The post California’s Top Revision Facelift Surgeons: Achieving Optimal Results appeared first on MedCity News.
Recent developments, including a high-profile acquisition and key regulatory changes, point to a paradigm shift. Cell and gene therapy is becoming increasingly commercially viable, with the potential to improve the lives of millions. The post A New Era for Cell and Gene Therapy Signals New Market Opportunities appeared first on MedCity News.
With staffing shortages, historic burnout, and rising costs, concierge medicine — and direct primary care (DPC) — have moved from the margins into the middle of the retention conversation. The post From Executive Perk to Employee Retention Strategy: Why Concierge Medicine and/or Direct Primary Care Is Now a Business Essential appeared first on MedCity News.